Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Nickel, T. Kempf, H. Golpon, K. Wollert, M. Wilkins, S. Gibbs, M. Hoeper (Hannover, Lower Saxony, Germany; London, United Kingdom). Growth-differentiation factor-15 as a prognostic indicator in idiopathic pulmonary arterial hypertension. Eur Respir J 2008; 32: Suppl. 52, 291

Member's Comments

No comment yet.

Related content which might interest you: Towards prognostic biomarkers in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 799-801 Year: 2012 Analysis of the cardiac index-PvO2 relationship during vasodilatation challenge as a prognostic factor in pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Determinants and prognostic value of kidney disease in pulmonary arterial hypertension Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 RV/TLC ratio as an independent prognostic indicator in idiopathic pulmonary arterial hypertension (IPAH) Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 342s Year: 2007 The prognostic role of the electrocardiogram in primary pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 414s Year: 2001 Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 912-914 Year: 2014 Echocardiography and pulmonary embolism severity index have independent prognostic roles in pulmonary embolism Source: Eur Respir J 2013; 42: 681-688 Year: 2013 Prognostic significance of pulmonary arterial pressure in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension Source: Eur Respir J, 53 (4) 1802067; 10.1183/13993003.02067-2018 Year: 2019 Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Prognostic role of cardiac troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Circulating angiopoietins in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Prognostic predictors in younger and older incident idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 Novel biomarkers in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 TAPSE as a prognostic factor in hemodinamically stable pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015 Hemoptysis in patients with non-Eisenmenger pulmonary arterial hypertension (PAH)– management and prognostic significance Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 Clinical and prognostic value of atrial natriutic peptide in patients with idiopathic pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006